Gram-negative bacteria
activity
cefiderocol
surveillance
Journal
Microbiology spectrum
ISSN: 2165-0497
Titre abrégé: Microbiol Spectr
Pays: United States
ID NLM: 101634614
Informations de publication
Date de publication:
27 04 2022
27 04 2022
Historique:
pubmed:
10
3
2022
medline:
30
4
2022
entrez:
9
3
2022
Statut:
ppublish
Résumé
Cefiderocol is a siderophore-conjugated cephalosporin with broad activity against Gram-negative (GN) bacteria, including carbapenem-resistant
Identifiants
pubmed: 35262394
doi: 10.1128/spectrum.02712-21
pmc: PMC9045385
doi:
Substances chimiques
Anti-Bacterial Agents
0
Carbapenems
0
Cephalosporins
0
Siderophores
0
Meropenem
FV9J3JU8B1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0271221Références
Antimicrob Agents Chemother. 2018 Jan 25;62(2):
pubmed: 29158270
Clin Infect Dis. 2020 Dec 3;71(9):e523-e529
pubmed: 32052041
Open Forum Infect Dis. 2019 Mar 15;6(Suppl 1):S1-S4
pubmed: 30895209
Clin Microbiol Infect. 2012 Mar;18(3):268-81
pubmed: 21793988
Clin Infect Dis. 2019 Nov 13;69(Suppl 7):S538-S543
pubmed: 31724047
Microb Drug Resist. 2020 Jul;26(7):722-726
pubmed: 32031915
Clin Infect Dis. 2019 Nov 13;69(Suppl 7):S544-S551
pubmed: 31724049
J Clin Microbiol. 2021 Nov 18;59(12):e0021321
pubmed: 34550809
Antimicrob Agents Chemother. 2020 Sep 21;64(10):
pubmed: 32718965
Open Forum Infect Dis. 2019 Mar 15;6(Suppl 1):S23-S33
pubmed: 30895212
Int J Antimicrob Agents. 2018 Nov;52(5):697-701
pubmed: 30081137
Antimicrob Agents Chemother. 2017 Dec 21;62(1):
pubmed: 29061741
Open Forum Infect Dis. 2019 Mar 15;6(Suppl 1):S34-S46
pubmed: 30895213
J Antimicrob Chemother. 2019 Feb 1;74(2):539
pubmed: 30445536